You have 9 free searches left this month | for more free features.
Clincosm LogoSign in Get a demo

Cell Division

Showing 26 - 50 of >10,000
STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS
LAST UPDATED

Small Cell Lung Cancer Trial in Italy (Etoposide, Carboplatin, Bevacizumab)

Active, not recruiting
  • Small Cell Lung Cancer
  • Bologna, Italy
  • +14 more
Sep 7, 2022

MCL, Mantle Cell Lymphoma Trial in Worldwide (Acalabrutinib-rituximab in patients with untreated mantle cell lymphoma)

Recruiting
  • MCL
  • Mantle Cell Lymphoma
  • Acalabrutinib-rituximab in patients with untreated mantle cell lymphoma
  • Odense, Denmark
  • +21 more
Feb 11, 2022

NSCLC Trial in United States (XL647)

Completed
  • Carcinoma, Non-Small-Cell Lung
  • Gilroy, California
  • +9 more
May 9, 2022

Esophageal Squamous Cell Carcinoma (ESCC) Trial in Japan, Taiwan (Pembrolizumab, Coformulation favezelimab/pembrolizumab,

Recruiting
  • Esophageal Squamous Cell Carcinoma (ESCC)
  • Pembrolizumab
  • +5 more
  • Milan, Lombardia, Italy
  • +13 more
Jan 3, 2023

Acute Myeloid Leukaemia Trial in Worldwide (S 64315 (also referred as MIK665) and azacitidine)

Active, not recruiting
  • Acute Myeloid Leukaemia
  • S 64315 (also referred as MIK665) and azacitidine
  • Houston, Texas
  • +6 more
Dec 16, 2022

Carcinoma, Renal Cell Trial in Worldwide (Pembrolizumab, MK-4830, Belzutifan)

Recruiting
  • Carcinoma, Renal Cell
  • Pembrolizumab
  • +5 more
  • New Haven, Connecticut
  • +38 more
Jan 25, 2023

Multiple Myeloma Trial in Torino (Melphalan, Prednisone, Lenalidomide, Cyclophosphamide, Prednisone, Lenalidomide, Lenalidomide,

Active, not recruiting
  • Multiple Myeloma
  • Melphalan, Prednisone, Lenalidomide
  • +2 more
  • Torino, TO, Italy
    Division Of Hematology, A.O.U. Città della Salute e della Scienz
Mar 24, 2022

Highly Sensitized Prospective Kidney Transplant Recipients Trial in San Francisco (daratumumab, belatacept, Bone marrow

Recruiting
  • Highly Sensitized Prospective Kidney Transplant Recipients
  • daratumumab
  • +2 more
  • San Francisco, California
    University of California at San Francisco Medical Center
Jan 27, 2022

NSCLC, Solid Tumor Trial in United States (Atezolizumab, Chemotherapy (Arm A Only), Tiragolumab)

Recruiting
  • Non-Small Cell Lung Cancer
  • Solid Tumor
  • Fort Myers, Florida
  • +6 more
Feb 16, 2022

Factors Associated With Development and Severity of Oral

Completed
  • Peripheral Blood Stem Cell Transplantation
  • Mucositis and nutritional assessments
  • San Antonio, Texas
  • +1 more
Jul 19, 2021

Digital Support of Patients With Inoperable Lung Cancer

Recruiting
  • Non-Small Cell Carcinoma of Lung, TNM Stage 4
  • Digital platform
  • Psychikó, Attiki, Greece
  • +14 more
May 12, 2022

NSCLC (NSCLC) Trial in Worldwide (Atezolizumab, Tiragolumab, Carboplatin)

Recruiting
  • Non-Small Cell Lung Cancer (NSCLC)
  • Duarte, California
  • +23 more
Aug 8, 2022

Home Care in Allogeneic Haematopoietic Stem Cell Transplantation

Not yet recruiting
  • Stem Cell Transplant Complications
  • +2 more
  • Home care
  • Oslo, Norway
    Department of Haematology, Division of Cancer Medicine, Oslo Uni
Jan 12, 2021

Acute Lymphocytic Leukemia, Adult Lymphoblastic Lymphoma Trial in United States (DNR, VCR, PEG-asp)

Terminated
  • Acute Lymphocytic Leukemia
  • Adult Lymphoblastic Lymphoma
  • La Jolla, California
  • +3 more
Apr 26, 2022

Nasopharyngeal Carcinoma, Nasopharyngeal Cancer, Nasopharyngeal Tumors Trial in Germany (drug, radiation, procedure, behavioral)

Recruiting
  • Nasopharyngeal Carcinoma
  • +3 more
  • Aachen, Germany
  • +28 more
Aug 24, 2023

Solid Tumors, Metastatic Melanoma, NSCLC Trial in Worldwide (RO7247669)

Recruiting
  • Solid Tumors
  • +3 more
  • San Diego, California
  • +20 more
Aug 19, 2022

Hypoplastic Left Heart Syndrome Trial in Atlanta, Baltimore, Ann Arbor (c-kit+ cells)

Recruiting
  • Hypoplastic Left Heart Syndrome
  • c-kit+ cells
  • Atlanta, Georgia
  • +2 more
Oct 5, 2021

Respiratory Tract Viral Infections, Human Metapneumovirus (hMPV) Infection, Parainfluenza (PIV) Infection Trial in United States

Recruiting
  • Respiratory Tract Viral Infections
  • +4 more
  • ALVR106
  • Placebo
  • Scottsdale, Arizona
  • +19 more
Apr 13, 2022

Urothelial Carcinoma Trial in France, Italy, United States (retifanlimab, epacadostat, INCAGN02385)

Recruiting
  • Urothelial Carcinoma
  • Iowa City, Iowa
  • +11 more
Dec 1, 2022

Chronic Lymphocytic Leukemia Trial in Haifa, Tel Aviv (COVID-19 serology)

Recruiting
  • Chronic Lymphocytic Leukemia
  • COVID-19 serology
  • Haifa, Israel
  • +1 more
Sep 11, 2021

Ann Arbor Stage III DLBCL, Ann Arbor Stage IIX (Bulky) DLBCL, Ann Arbor Stage IV DLBCL Trial in United States (drug, other,

Suspended
  • Ann Arbor Stage III Diffuse Large B-Cell Lymphoma
  • +20 more
  • Tucson, Arizona
  • +110 more
Jan 31, 2023

MDS, Acute Leukemia Trial in Germany (CIK-Cells)

Active, not recruiting
  • Myelodysplastic Syndromes
  • Acute Leukemia
  • Heidelberg, Baden-Württemberg, Germany
  • +4 more
Mar 31, 2022

Pemphigus Foliaceus, Pemphigus Vulgaris Trial in United States (Cohort 1: 1.0 x 10^8 PolyTregs, Cohort 2: 2.5x10^8 PolyTregs)

Active, not recruiting
Has Results
  • Pemphigus Foliaceus
  • Pemphigus Vulgaris
  • Cohort 1: 1.0 x 10^8 PolyTregs
  • Cohort 2: 2.5x10^8 PolyTregs
  • San Francisco, California
  • +3 more
Oct 22, 2021

Carcinoma, Renal Cell Trial in Worldwide (Pembrolizumab, Favezelimab/Pembrolizumab, Belzutifan)

Recruiting
  • Carcinoma, Renal Cell
  • Pembrolizumab
  • +5 more
  • New Haven, Connecticut
  • +37 more
Jan 25, 2023

Advanced Solid Tumors Cancer Trial in Worldwide (ABBV-368, Tilsotolimod, Nab-paclitaxel)

Active, not recruiting
  • Advanced Solid Tumors Cancer
  • Chicago, Illinois
  • +25 more
Mar 9, 2022